BIS
ProShares UltraShort Nasdaq Biotechnology
13.8 9 USD
+0.02%
Sector: Financial
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.13%
Monthly Change
-7.95%
6 month change
+57.84%
Year Change
-8.98%
Previous Close
13.6 0
Open
13.8 7
Low
13.8 7
High
13.8 9
Volume
2
Top holdings Market Value Weight %
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|
| 1 |  GSJY Goldman Sachs ActiveBeta Japan Equity ETF | 52.24 USD | -0.23% | +0.62% | +0.73% | +21.43% | ||
| 2 |  VPU Vanguard Utilities ETF | 198.49 USD | +2.18% | +1.50% | +1.40% | +8.88% | ||
| 3 |  FTAG First Trust Indxx Global Agriculture ETF | 29.58 USD | +0.82% | +1.20% | +5.27% | +8.19% | ||
| 4 |  AETH Bitwise Funds Trust Bitwise Ethereum Strategy ETF | 31.53 USD | +0.48% | +0.38% | +7.98% | -38.51% |
Frequently asked questions about ProShares UltraShort Nasdaq Biotechnology
What is an ETF?
An exchange-traded fund, or ETF, is a basket of assets such as stocks, bonds, commodities, or other instruments. ETFs trade on exchanges like regular stocks and often aim to track an index, sector, strategy, or asset class.
What is the BIS price today?
BIS is trading at 13.89 today. Over the past 24 hours, its price has changed by +2.13%. Follow the BIS chart to monitor current market dynamics.
How can I invest in an ETF like BIS?
ETFs such as BIS can be bought and sold through brokers. Before investing, compare fees, liquidity, tracking quality, and whether the ETF fits your strategy.
What does BIS invest in?
BIS is ProShares UltraShort Nasdaq Biotechnology. Review the analysis section on metatrader.com to see the asset mix, sector exposure, and concentration of the ETF.
What is the expense ratio of BIS?
The expense ratio shows the annual operating cost of holding an ETF relative to its assets. Check the BIS fund statistics on metatrader.com to compare its costs with similar ETFs.
Is BIS leveraged?
Review the fund profile of BIS to confirm whether it uses leverage. Leveraged ETFs use borrowing or derivatives to amplify returns and usually carry higher risk than non-leveraged funds.
Should I buy or sell BIS?
A decision to buy or sell BIS should be based on the fund's holdings, costs, liquidity, NAV behavior, technical picture, and your risk profile. Use the chart, fund data, and market news before making a decision.
Who issues BIS?
BIS is issued by ProShares UltraShort Nasdaq Biotechnology. The issuer is responsible for managing the ETF according to its stated objective and methodology.
What index does BIS track?
BIS is ProShares UltraShort Nasdaq Biotechnology. Check the ETF profile to see the benchmark, replication method, and investment objective of the fund.
How is BIS managed?
ETF management depends on the fund's objective. BIS may use a passive or active approach; review the fund profile to understand how it selects, weights, and rebalances its holdings.